Media Summary: Camillo Porta, MD, University of Bari Aldo Moro, Bari, Italy, comments on the Andrea B. Apolo, MD, principal investigator and head of the Bladder Cancer Section in the Genitourinary Malignancies Branch at ... Benoit You, MD, PhD, Centre Hospitalier Lyon-Sud, Saint-Genis-Laval, France, discusses the Phase II TROPHIMMUN trial ...
Final Results Of Avelumab And - Detailed Analysis & Overview
Camillo Porta, MD, University of Bari Aldo Moro, Bari, Italy, comments on the Andrea B. Apolo, MD, principal investigator and head of the Bladder Cancer Section in the Genitourinary Malignancies Branch at ... Benoit You, MD, PhD, Centre Hospitalier Lyon-Sud, Saint-Genis-Laval, France, discusses the Phase II TROPHIMMUN trial ... Andrea B. Apolo, MD, principal investigator and the head of the Bladder Cancer Section in the Genitourinary Malignancies Branch ... Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, discusses ... Joaquim Bellmunt, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, discusses
Hiroshi Kitamura, MD, PhD, University of Toyama, Toyama, Japan, discusses Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New ... Anand Sharma, MD, DPhil, MBBS, MRCP, Mount Vernon Cancer Centre, Northwood, UK, provides an overview of Kevin Harrington, MD, PhD, FRCP, FRCR, FRSB, The Institute of Cancer Research and The Royal Marsden NHS Foundation ... Sandra P. D'Angelo, MD, from the Memorial Sloan-Kettering Cancer Center, New York, NY discusses potential treatments, namely ... Roberto Iacovelli, MD, Agostino Gemelli University Policlinic, Rome, Italy, gives an overview of the Phase II TIDE-A trial ...
Dr Motzer speaks with ecancer at ESMO 2018 in Munich about
